Nitroglycerin Teva (Glyceryl Trinitrate)

Glyceryl Trinitrate, the active ingredient in Nitroglycerin Teva, is an organic nitrate presented as a cutaneous formulation for transdermal use. It is employed to relieve and prevent episodes of chest pain in patients with coronary artery disease and to improve symptoms of certain types of heart failure.

GNH USA supplies Nitroglycerin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand through reliable logistics and dedicated customer support.

Nitroglycerin Teva, an organic nitrate, is used in the management of several cardiovascular conditions.

- Angina pectoris: provides rapid relief of chest pain by dilating coronary vessels and reducing myocardial oxygen demand. - Prophylaxis of angina attacks: helps prevent recurrent episodes through sustained vasodilation and preload reduction. - Heart failure: improves symptoms by decreasing ventricular filling pressures and enhancing cardiac output.

Nitroglycerin Teva may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: throbbing pain often occurring shortly after application. - Dizziness or light‑headedness: due to transient blood pressure drop. - Flushing: warm sensation and redness of the skin. - Hypotension: mild reduction in blood pressure. - Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to fainting. - Syncope: sudden loss of consciousness. - Myocardial infarction: rare worsening of heart ischemia. - Allergic reaction: rash, itching, or swelling. - Methemoglobinemia: abnormal hemoglobin causing cyanosis.

When prescribing Nitroglycerin Teva, clinicians should observe several safety considerations.

- Blood pressure monitoring: check for excessive hypotension after dose adjustments. - Concomitant vasodilators: avoid combining with other nitrates or potent vasodilators to prevent severe blood pressure fall. - Phosphodiesterase‑5 inhibitors: contraindicated due to risk of profound hypotension. - Cardiovascular status: use cautiously in patients with severe aortic stenosis or hypertrophic cardiomyopathy. - Tolerance development: assess need for nitrate‑free intervals to maintain efficacy. - Store at room temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Nitroglycerin Teva can interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid): - Other nitrates (e.g., isosorbide dinitrate): may cause additive hypotensive effects. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of severe blood pressure reduction. - Guanylate cyclase stimulators: can amplify vasodilation leading to dangerous hypotension.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors): may enhance blood pressure‑lowering effect. - Diuretics: can increase risk of orthostatic hypotension. - Alcohol: may potentiate vasodilatory response and dizziness.